Monographie - Bevacizumab - Stabilis 4.0

Viimeisin päivitys :
28/04/2024

Syöpälääke

Bevacizumab

Injektioneste

Silmätipat

Stabilius liuoksessa

Stabilius seoksissa

Tekijät, jotka vaikuttavat stabiliuteen

Yhteensopivuus

Antotapa

Viitteet

Pdf

Kauppanimi

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Altuzan	Turkki
Alymsis	Ranska
Avastin	Argentiina, Australia, Belgia, Brasilia, Chile, Espanja, Hollanti, Irlanti, Islanti, Iso-Britannia, Italia, Itävalta, Japani, Kanada, Kolumbia, Kreikka, Luxemburg, Malesia, Marokko, Marokko, Meksiko, New Zealand, Norja, Portugali, Puola, Ranska, Romania, Ruotsi, Saksa, Suomi, Sveitsi, Tanska, Tunisia, Unkari, Venezuela, Yhdistyneet arabiemiirikunnat, Yhdysvallat
Aybintio	Ranska
Bevax	Argentiina
Zyrabev	Ranska

Viitteet

Injektioneste

Viitteet : Bevacizumab

	Tyyppi	Julkaisu
2296	Laboratorio	Témocilline (Negaban®) - Résumé des caractéristiques du produit Eumedica 2017
2661	Lehti	Khalili H, Sharma G, Froome A, Khaw P.T, Brocchini S. Storage stability of bevacizumab in polycarbonate and polypropylene syringes Eye 2015 ; 29, 6: 820-827.
2882	Ilmoitus	Morand K, Paul M, Lahlou A, Blanchet B, Astier A. Stabilité de solutions diluées de bévacizumab en fonction de la température. SFPO Congress 2009
3265	Ilmoitus	Vieillard V, Cauvin A, Roumi E, Despiau MC, Laurent M, Voytenko S, Astier A, Paul M. Stabilité physico-chimique du bévacizumab à 25 mg/mL conservée à 4°C en seringue polypropylène. SFPO Congress, France 2011
3312	Lehti	Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M.C, Laurent M, Astier A. Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration. Ann Pharm Fr 2012 ; 70, 3: 139-154.
4467	Laboratorio	Avastin - Summary of Product Characteristics Roche Products Limited 2020
4516	Lehti	Seckute J, Castellanos I, Bane S. Physicochemical stability of the bevacizumab biosimilar, ABP 215, after preparation and storage in intravenous bags. GaBI Journal 2020 ; 9, 4:155-162
4525	Lehti	Park D, Kim J, Yun J, Park S.J. Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions. Adv Ther 2020 ; 37: 4308–4324.
4714	Ilmoitus	Vieillard V, Paul M Etude de stabilité d'un biosimilaire du Bevacizumab dans les flacons et après dilution dans du NaCl 0.9% en poche de polyoléfine. GERPAC Congrès - octobre 2022 2022
4744	Laboratorio	Stability Report of Extended SB8 Opened Vial (400 mg) Stability (personal communication). Samsung laboratory 2023
4745	Lehti	Vieillard V, Paul M Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags. Pharmaceutical Technology in Hospital Pharmacy 2023
4756	Lehti	Weiser S, Burns C, Zartler E. Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice 2022 ;29, 5: 1032-1043
4798	Lehti	Gjølberg T, Lode H, Melo G, Mester S,Probst C, Sivertsen M, Jørstad ø, Andersen J, Moe M. A silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics. Frontiers in Ophthalmology 2022 ;2

Mentions Légales